Page last updated: 2024-11-02

pentamidine and Endometrial Neoplasms

pentamidine has been researched along with Endometrial Neoplasms in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.

Research Excerpts

ExcerptRelevanceReference
"Pentamidine has been reported to have many pharmacological effects including anti- protozoal, anti-inflammatory, and anti-tumor activities."1.72Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway. ( Gao, Y; Hu, X; Lin, L; Liu, C; Ouyang, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lin, L3
Gao, Y3
Hu, X3
Ouyang, J3
Liu, C3

Other Studies

1 other study available for pentamidine and Endometrial Neoplasms

ArticleYear
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
    BMC women's health, 2022, 11-24, Volume: 22, Issue:1

    Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall

2022